UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 23, 2015
Accession Number:
Submission Type:
CIK: 0001604464
Company Name: Atara Biotherapeutics, Inc.
File Number: 333-207876